You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Peroxisome Proliferator-Activated Receptor alpha (PPARA) Antibodies

Full name:
anti-Peroxisome Proliferator-Activated Receptor alpha Antibodies (PPARA)
On www.antibodies-online.com are 245 Peroxisome Proliferator-Activated Receptor alpha (PPARA) Antibodies from 26 different suppliers available. Additionally we are shipping Peroxisome Proliferator-Activated Receptor alpha Kits (47) and Peroxisome Proliferator-Activated Receptor alpha Proteins (12) and many more products for this protein. A total of 315 Peroxisome Proliferator-Activated Receptor alpha products are currently listed.
Synonyms:
4933429D07Rik, AW742785, hPPAR, LOC100136415, nr1c1, PPAR, PPAR-alpha, PPARALPHA, xppara, xPPARalpha
list all antibodies Gene Name GeneID UniProt
PPARA 19013 P23204
PPARA 25747 P37230
PPARA 5465 Q07869

Show all species

Show all synonyms

Most Popular Reactivities for anti-Peroxisome Proliferator-Activated Receptor alpha (PPARA) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

anti-Human Antibodies:

All available anti-Peroxisome Proliferator-Activated Receptor alpha Antibodies

Go to our pre-filtered search.

Top referenced anti-Peroxisome Proliferator-Activated Receptor alpha Antibodies

  1. Human Polyclonal PPARA Primary Antibody for IF, ELISA - ABIN1532643 : Sher, Yi, McBride, Gonzalez: cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. in Biochemistry 1993 (PubMed)
    Show all 2 references for ABIN1532643

  2. Human Polyclonal PPARA Primary Antibody for EIA, FACS - ABIN954264 : Jablonski, McAteer, de Bakker, Franks, Pollin, Hanson, Saxena, Fowler, Shuldiner, Knowler, Altshuler, Florez: Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. in Diabetes 2010 (PubMed)
    Show all 2 references for ABIN954264

  3. Mouse (Murine) Polyclonal PPARA Primary Antibody for IHC, ELISA - ABIN1043876 : Mukherjee, Jow, Noonan, McDonnell: Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. in The Journal of steroid biochemistry and molecular biology 1995 (PubMed)
    Show all 2 references for ABIN1043876

  4. Chicken Polyclonal PPARA Primary Antibody for WB - ABIN2777734 : Kourimate, Le May, Langhi, Jarnoux, Ouguerram, Zaïr, Nguyen, Krempf, Cariou, Costet: Dual mechanisms for the fibrate-mediated repression of proprotein convertase subtilisin/kexin type 9. in The Journal of biological chemistry 2008 (PubMed)

  5. Mouse (Murine) Polyclonal PPARA Primary Antibody for IHC, ELISA - ABIN105798 : Zak, Gelebart, Lai: Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis. in Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2010 (PubMed)

  6. Cow (Bovine) Polyclonal PPARA Primary Antibody for WB - ABIN223278 : Hennessy, Sheedy, Santamaria, Barbacid, ONeill: Toll-like receptor-4 (TLR4) down-regulates microRNA-107, increasing macrophage adhesion via cyclin-dependent kinase 6. in The Journal of biological chemistry 2011 (PubMed)

  7. Chicken Polyclonal PPARA Primary Antibody for WB - ABIN2778267 : Sérée, Villard, Pascussi, Pineau, Maurel, Nguyen, Fallone, Martin, Champion, Lacarelle, Savouret, Barra: Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. in Gastroenterology 2004 (PubMed)

  8. Mouse (Murine) Polyclonal PPARA Primary Antibody for FACS, WB - ABIN656834 : Spruiell, Richardson, Cullen, Awumey, Gonzalez, Gyamfi: Role of pregnane X receptor in obesity and glucose homeostasis in male mice. in The Journal of biological chemistry 2014 (PubMed)

More Antibodies against Peroxisome Proliferator-Activated Receptor alpha Interaction Partners

Mouse (Murine) Peroxisome Proliferator-Activated Receptor alpha (PPARA) interaction partners

  1. the protective effect of PPARalpha activation against cardiac ischemia-reperfusion injury in terms of the expression of uncoupling protein (show UCP3 Antibodies) (UCP (show UCP1 Antibodies)), was investigated.

  2. This study evaluated the effects of Boiogito on kidney proximal epithelial cells via the PPARalpha-CREB (show CREB1 Antibodies) protein complex.

  3. miR (show MLXIP Antibodies)-130b played important profibrotic roles in SSc (show CYP11A1 Antibodies) fibrosis, and enhanced TGF-beta (show TGFB1 Antibodies) signaling through negative regulation of PPARgamma (show PPARG Antibodies) expression.

  4. Downregulation of miR (show MLXIP Antibodies)-34a may be a therapeutic strategy against nonalcoholic fatty liver disease by regulating its target PPARalpha and SIRT1 (show SIRT1 Antibodies).

  5. hepatic CEACAM1 (show CEACAM1 Antibodies) expression at fasting is mediated by Pparalpha-dependent mechanisms.

  6. Bilirubin Binding to PPARalpha Inhibits Lipid Accumulation

  7. Pparalpha complex translocates from the cytoplasm into the nucleus and further recruits coactivators and transcription machinery which induce the transcription of Abcg2 (show ABCG2 Antibodies) gene and ultimately results in upregulation of Bcrp (show ABCG2 Antibodies) protein expression and function

  8. Cardiac myocyte KLF5 (show KLF5 Antibodies) is a transcriptional regulator of Ppara and cardiac energetics.

  9. prior voluntary exercise suppresses the expression of pro-inflammatory cytokines in the colon in response to inflammatory challenge by up-regulating glucocorticoid-mediated PPAR-gamma (show PPARG Antibodies) activity

  10. The optimal PPARalpha/RXRalpha (show RXRA Antibodies) heterodimer binding sequence was WAWVTRGGBBAHRGKTYA. The single nucleotide substitution, which reduces binding of RXRalpha (show RXRA Antibodies) to DNA, attenuated PPARalpha-induced transcriptional activation, but this is not always true for PPARalpha.

Xenopus laevis Peroxisome Proliferator-Activated Receptor alpha (PPARA) interaction partners

Human Peroxisome Proliferator-Activated Receptor alpha (PPARA) interaction partners

  1. results support an important association between rs1800206 minor allele (V) of PPAR alpha and lower CRP (show CRP Antibodies) level; the interaction analysis showed a combined effect between rs1800206 and rs135539 on the lower CRP (show CRP Antibodies) level

  2. PPAR-gamma (show PPARG Antibodies) and PTEN (show PTEN Antibodies) expressions are related to the clinical parameters and prognosis of renal cell carcinoma (show MOK Antibodies)

  3. Describe a renoprotective role of fenofibrate in albumin (show ALB Antibodies) bound fatty acid associated tubular toxicity, involving the transcriptional activation of PPARalpha and suppression of NF-kB.

  4. Supplementation with the PPARalpha agonist WY14643 improved the homeostasis and barrier function of filaggrin (show FLG Antibodies) deficient skin models by normalization of the free fatty acid profile.

  5. Downregulation of miR (show MLXIP Antibodies)-34a may be a therapeutic strategy against nonalcoholic fatty liver disease by regulating its target PPARalpha and SIRT1 (show SIRT1 Antibodies).

  6. PPAR agonists troglitazone and aleglitazar reverse doxorubicin resistance of human myelogenous leukemia cells.

  7. we show that fenofibrate, a PPAR-alpha agonist, increased the expression of miR (show MLXIP Antibodies)-301a/miR (show MLXIP Antibodies)-454 and SKA2 (show FAM33A Antibodies) in human microvascular endothelial cell line (HMEC) cells; the former were responsible for reduced expression of ET-1 (show EDN1 Antibodies) and PAI-1 (show SERPINE1 Antibodies)

  8. this is the first study to report that 9-oxo-OTA promotes fatty acid metabolism via PPARalpha activation and discuss its potential as a valuable food-derived compound for use in the management of dyslipidemia.

  9. Evidence that multiple PPARalpha/delta/gamma gene polymorphisms are individually associated with increased low-density lipoprotein-cholesterol, and that interactions, among these alleles result in additional increased risk suggesting that PPAR genes may contribute substantially to the risk of cardiovascular diseases and atherosclerosis.

  10. Both PPARA and PPARGC1A (show PPARGC1A Antibodies) regulate transcription of genes commonly regulated by glycolysis, by the antidiabetic agent metformin and by NOX, suggesting their major interplay in the control of hepatocellular carcinoma progression

Pig (Porcine) Peroxisome Proliferator-Activated Receptor alpha (PPARA) interaction partners

  1. The c.*636A>G SNP in the PPARA gene can be considered in Polish Landrace breed as a useful genetic marker for adipose tissue accumulation.

  2. The results indicate that the endometrial expression of PPARalpha genes fluctuates during the estrous cycle and pregnancy.

  3. PPARalpha is likely to play a central role in adaptation to fasting in pig liver

  4. Despite expression of PPAR-alpha in porcine myocardium and effects of fenofibrate on systemic metabolism, treatment with this PPAR-alpha activator does not alter myocardial metabolic or contractile responses to I/R in pigs.

  5. FISH localization of 4 BAC clones harbouring potential candidate genes for fatness traits: DGAT1 (show DGAT1 Antibodies) (SSC4p15), PPARA (SSC5p15), ADIPOR1 (show ADIPOR1 Antibodies) (SSC10p13) and CREB (show CREB1 Antibodies) (SSC15q24)

  6. PPAR profiles in bladder smooth muscle (BSM) may contribute to the susceptibility of BSM to lipotoxicity in the metabolic syndrome.

Cow (Bovine) Peroxisome Proliferator-Activated Receptor alpha (PPARA) interaction partners

  1. This study investigated FA composition in yaks and cattle, in order to ascertain whether a correlation between PPARalpha signal pathway genes as candidate genes and meat FA composition in yaks and cattle exists.

  2. OCTN2 (show SLC22A5 Antibodies) expression and carnitine transport in cattle, as in rodents, are regulated by PPARalpha.

  3. In conclusion, H8H8 haplotype combination of the PPARalpha may be advantageous for heat resistance traits in Chinese Holstein cattle.

  4. Data suggest that PPARalpha (but not PPARgamma (show PPARG Antibodies)) is involved in vasorelaxation of ophthalmic artery in response to endocannabinoids (i.e., anandamide, palmitoylethanolamide); endothelium removal slightly decreases the response to endocannabinoids.

  5. Data from gene profiling experiments in bovine cell line support hypothesis that saturated long-chain fatty acids modulate ruminant lipid metabolism and expression of inflammation mediators with major effects induced via activation of PPARalpha.

  6. Dietary trans fatty acids may affect liver lipid metabolism in post-partum dairy cows through alterations in PPARalpha gene expression.

  7. Oxidized fataprevent an alcohol-induced triacylglycerol accumulation in rats possibly by upregulation of hepatic PPARalpha-responsive genes, whwereas conjugated linoleic acid does not.

  8. The results are consistent with the hypothesis that arachidonic acid acts via PPARalpha to increase PTGS2 (show PTGS2 Antibodies) levels in bovine endometrial stromal cells.

Peroxisome Proliferator-Activated Receptor alpha (PPARA) Antigen Profile

Antigen Summary

Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers\; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined.

Alternative names and synonyms associated with Peroxisome Proliferator-Activated Receptor alpha (PPARA)

  • peroxisome proliferator-activated receptor alpha (LOC100136415) antibody
  • peroxisome proliferative activated receptor, alpha (PPAR-ALPHA) antibody
  • peroxisome proliferator activated receptor alpha (Ppara) antibody
  • peroxisome proliferator activated receptor alpha (PPAR ALPHA) antibody
  • peroxisome proliferator activated receptor alpha (ppara) antibody
  • peroxisome proliferator-activated receptor alpha (PPARA) antibody
  • peroxisome proliferator-activated receptor alpha (ppara) antibody
  • 4933429D07Rik antibody
  • AW742785 antibody
  • hPPAR antibody
  • LOC100136415 antibody
  • nr1c1 antibody
  • PPAR antibody
  • PPAR-alpha antibody
  • PPARALPHA antibody
  • xppara antibody
  • xPPARalpha antibody

Protein level used designations for PPARA

peroxisome proliferator-activated receptor alpha , ppar alpha , peroxisome proliferator activated receptor alpha , peroxisome proliferator-activated receptor-alpha , nuclear receptor subfamily 1 group C member 1 , PPAR-alpha , peroxisome proliferative activated receptor, alpha , peroxisome proliferator-activated nuclear receptor alpha variant 3 , PPAR alpha , xPPAR alpha

GENE ID SPECIES
100136415 Salmo salar
100356422 Oryctolagus cuniculus
19013 Mus musculus
25747 Rattus norvegicus
443457 Ovis aries
100135604 Cavia porcellus
398843 Xenopus laevis
5465 Homo sapiens
403654 Canis lupus familiaris
496107 Xenopus laevis
374120 Gallus gallus
397239 Sus scrofa
100009308 Oryctolagus cuniculus
281992 Bos taurus
Selected quality suppliers for anti-Peroxisome Proliferator-Activated Receptor alpha (PPARA) Antibodies
Did you look for something else?